(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $1781.65 | $1978.38 | $1742.53 | $1660.66 |
Inventory | $2921.83 | $3133.55 | $3258.61 | $3448.82 |
Total current assets | $6146.45 | $7402.39 | $6692.82 | $6558.53 |
Long term investments | ||||
Property, plant & equipment | $6974.84 | $6906.09 | $6945.99 | $6987.26 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $17716.26 | $18901.81 | $18197.01 | $18006.01 |
Current liabilities | ||||
Accounts payable | $2205.76 | $2366.27 | $2001.21 | $2109.24 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $2774.55 | $3477.22 | $2887.91 | $3117.73 |
Long term debt | $2739.08 | $2861.96 | $2888.47 | $2932.99 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $7547.18 | $9077.13 | $8488.05 | $8735.34 |
Shareholders' equity | ||||
Retained earnings | $5379.18 | $5523.24 | $4815.91 | $4395.53 |
Other shareholder equity | -$11.78 | -$24.74 | -$13.38 | -$20.22 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $1781.65 | $1756.71 | $1339.27 | $721.38 |
Inventory | $2921.83 | $3214.53 | $2122.13 | $1173.48 |
Total current assets | $6146.45 | $6748.32 | $3762.45 | $3310.76 |
Long term investments | ||||
Property, plant & equipment | $6974.84 | $7039.97 | $5811.05 | $4923.69 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $17716.26 | $18125.48 | $12916.61 | $11506.86 |
Current liabilities | ||||
Accounts payable | $2205.76 | $2334.11 | $1613.48 | $1000.96 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $2774.55 | $3245.53 | $2065.46 | $1375.16 |
Long term debt | $2813.94 | $2998.87 | $3129.29 | $3147.82 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $7547.18 | $8881.67 | $7228.73 | $6338.5 |
Shareholders' equity | ||||
Retained earnings | $5379.18 | $4130.25 | $4413.84 | $3913.18 |
Other shareholder equity | -$11.78 | -$22.01 | $2.67 | $13.46 |
Total shareholder equity |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $10599 | $11162.16 | $7458.75 | $5622.67 |
Cost of revenue | ||||
Gross Profit | $2206.9 | $2547.7 | $965.29 | $655.77 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $868.54 | $868.05 | $706.46 | $657.68 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $301.85 | $383.49 | $21.33 | -$26.05 |
Interest expense | -$49.8 | -$32.58 | -$30.1 | -$25.17 |
Net income | ||||
Net income | $954.4 | $1221.26 | $159.97 | -$39.53 |
Income (for common shares) |
(in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $18389.14 | $11183.64 | $17486.58 | $17714.67 |
Cost of revenue | ||||
Gross Profit | $3132.21 | $1946.34 | $3702.37 | $3654.23 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $2327.63 | $2132.79 | $2256.84 | $2012.62 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $123.9 | -$232.15 | $299.15 | $355.04 |
Interest expense | -$111.66 | -$110.05 | -$126.32 | -$120.07 |
Net income | ||||
Net income | $558.32 | -$601.45 | $772.39 | $1097.96 |
Income (for common shares) |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$665.83 | -$539.01 | -$385.18 | -$1327.22 |
Financing activities | ||||
Dividends paid | -$175.43 | -$90.16 | -$57.66 | |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$975.48 | $20.17 | $281.39 | -$211.8 |
Effect of exchange rate | -$7.99 | -$2.71 | $0.59 | -$1.53 |
Change in cash and equivalents | $1212.91 | $1467.84 | $357.84 | -$1133.87 |
(in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1327.22 | -$330.16 | -$972.91 | -$360.52 |
Financing activities | ||||
Dividends paid | -$57.66 | -$229.49 | -$225.17 | -$233.54 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$211.8 | $353.23 | -$848.25 | -$664.33 |
Effect of exchange rate | -$1.53 | $2.16 | $2.97 | -$5.57 |
Change in cash and equivalents | -$1133.87 | $483.16 | -$269.58 | $524 |
Market cap | $11.49B |
---|---|
Enterprise value | N/A |
Shares outstanding | 200.00M |
Revenue | $34.84B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $2.30B |
Revenue Q/Q | 126.23% |
Revenue Y/Y | 81.74% |
P/E ratio | 5.00 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 0.33 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | $11.48 |
---|---|
ROA | 12.61% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 2.22 |
Quick ratio | 1.16 |